C2N Diagnostics, a recognized global leader in advanced brain health diagnostics, has taken an important step forward in the fight against Alzheimer’s disease. The company has formally submitted its innovative blood test to the U.S. Food and Drug Administration (FDA)…
Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. and long recognized as a pioneer in clinical genomic testing, has announced a significant enhancement to its Ambry CARE Program® (CARE). The program, a digital platform designed to streamline…
Thermo Fisher Scientific and AstraZeneca BioVentureHub Announce Strategic R&D Partnership to Advance Life Science Innovation. The PPD™ clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, today announced a new research and development (R&D) partnership…
AliveGen USA Inc. (AliveGen), a clinical-stage biopharmaceutical company focused on developing novel therapies for serious cardiopulmonary diseases, today announced compelling new preclinical results for its investigational therapy ALG-801. The data show that ALG-801 delivered superior efficacy compared with current standard-of-care…
PINC Technologies, a Caltech spinout developing advanced integrated nonlinear photonic devices and circuits, announced the close of its Seed+ financing round, bringing total funds raised to date to $6.8 million. The funding marks a major milestone for the young company…
Serenity Mental Health Centers, one of the nation’s fastest-growing providers of psychiatric care and the largest provider of Deep Transcranial Magnetic Stimulation (Deep TMS™) in the United States, today announced that its patients can now immediately benefit from the FDA’s…
Planet Labs PBC, a global leader in daily Earth data and insights, announced today that two of its latest high-resolution Pelican satellites, Pelican-5 and Pelican-6, along with 36 SuperDoves from Flock 4H, have successfully arrived at Vandenberg Space Force Base…
CytoAgents, Inc., a clinical-stage biotechnology company focused on developing safe and effective preventative therapies for life-threatening immune-related toxicities, today announced it has been awarded a $2.25 million grant from the National Institutes of Health (NIH). This grant, issued through the…
Predicta Biosciences, a precision oncology company pioneering next-generation diagnostic and therapeutic discovery solutions, today announced the successful close of a $23.4 million oversubscribed Series A financing round. The investment was led by Engine Ventures, with strong participation from Illumina Ventures,…
Colossal Biosciences, known worldwide as the first and only company dedicated to de-extinction, has reached a groundbreaking milestone. Today, the team celebrates the first birthday of Romulus and Remus—the first living dire wolves in over 12,500 years. Once thought lost…